Home › Premarket Biotech Digest: Gilead Gets A Boost, Zafgen's Beloranib Program, Relypsa Gets FDA Nod
 

Keywords :   


Premarket Biotech Digest: Gilead Gets A Boost, Zafgen's Beloranib Program, Relypsa Gets FDA Nod

2015-10-24 12:08:16| Biotech - Topix.net

Parkinson's is very difficult to diagnose- in fact, there's no real diagnostic test for PD. A doctor usually looks at your medical history, maybe some changes in behavior, and may conduct blood tests and scans to eliminate other diseases.

Tags: program boost digest biotech

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
20.05Eastern North Pacific Tropical Weather Outlook
20.05Atlantic Tropical Weather Outlook
20.05Water investors have withdrawn billions, says research
19.05Atlantic Tropical Weather Outlook
19.05Eastern North Pacific Tropical Weather Outlook
19.05IT Cosmetics and Kenvue Launch New Products
19.05Virgin Trains targets West Coast in return to rail
19.05Cashing In On The Stache
More »